Tenet director awarded 1,188 restricted stock units

Tenet Healthcare director Christopher S. Lynch received a grant of 1,188 restricted stock units tied to common stock.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Tenet Healthcare director Christopher S. Lynch received a grant of 1,188 restricted stock units tied to common stock. These 2026 May Restricted Stock Units were awarded at no exercise price and are structured as equity-based compensation.

The units vest on the first anniversary of the grant date, 27 May 2027, meaning Lynch must remain eligible through that date to receive the shares or cash. Each unit is the economic equivalent of one share of Tenet’s common stock, and Lynch may elect to receive up to 37% of the vested units in cash instead of shares.

Insider Trade Summary

Grant/Award: 1,188 shares

Grant/Award 1 txn

Insider Lynch Christopher S.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	2026 May Restricted Stock Units	1,188	$0.00	$0.00

Holdings After Transaction: 2026 May Restricted Stock Units — 1,188 contracts (Direct)

Footnotes (1)

F1. Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares.

Key Figures

Restricted stock units granted: 1,188 units Exercise price: $0.0000 per unit Underlying common shares: 1,188 shares +5 more

8 metrics

Restricted stock units granted 1,188 units Grant of 2026 May Restricted Stock Units

Exercise price $0.0000 per unit RSU grant terms

Underlying common shares 1,188 shares Each RSU equals one common share

Cash election cap 37% Portion of RSUs that may be taken in cash

Grant date 27 May 2026 Transaction date for RSU award

Vesting date 27 May 2027 RSUs vest on first anniversary of grant

Expiration date 27 May 2027 RSU expiration per filing

Holdings after transaction 1,188 derivative units Total RSUs held following this award

Key Terms

restricted stock units, Stock Incentive Plan, economic equivalent, vest, +1 more

5 terms

restricted stock units financial

"Represents restricted stock units granted under the Company's Stock Incentive Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Incentive Plan financial

"Represents restricted stock units granted under the Company's Stock Incentive Plan."

A stock incentive plan is a company program that gives employees or directors pieces of ownership or the right to buy shares over time, similar to receiving a bonus paid in company stock instead of cash. Investors pay attention because these plans align staff incentives with long‑term company performance but can also dilute existing shareholders and affect reported profits when grants are expensed, so they influence both ownership percentages and financial results.

economic equivalent financial

"Each restricted stock unit is the economic equivalent of one share of the Company's common stock."

vest financial

"These restricted stock units vest on the first anniversary of the date of grant."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

cash in lieu of shares financial

"The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Tenet Healthcare (THC) director Christopher S. Lynch report on this Form 4?

Christopher S. Lynch reported receiving 1,188 restricted stock units as equity compensation. These units represent potential future value equivalent to Tenet Healthcare common shares, subject to a vesting schedule and an option to take part of the award in cash.

How many restricted stock units did Christopher Lynch receive from Tenet Healthcare (THC)?

Christopher Lynch received 1,188 restricted stock units in this grant. Each unit is the economic equivalent of one share of Tenet Healthcare common stock, providing additional equity-based incentive aligned with shareholder interests if the vesting conditions are met.

When do Christopher Lynch’s Tenet Healthcare (THC) restricted stock units vest?

The 1,188 restricted stock units vest on the first anniversary of the grant date, 27 May 2027. Lynch generally must satisfy the required service or eligibility conditions through that date before the award converts into shares or cash value.

Can Christopher Lynch take part of his Tenet Healthcare (THC) RSU award in cash?

Yes. Lynch may elect to receive up to 37% of the vested restricted stock units in cash instead of shares. The remaining portion would be settled in Tenet Healthcare common stock, according to the plan’s terms and his election.

What is the economic value structure of Christopher Lynch’s Tenet Healthcare (THC) RSUs?

Each of the 1,188 restricted stock units is the economic equivalent of one share of Tenet Healthcare common stock. Although granted at a zero exercise price, actual value realization depends on vesting and the company’s share price at settlement.

Does this Tenet Healthcare (THC) Form 4 show any stock sales by Christopher Lynch?

This Form 4 shows only a grant of 1,188 restricted stock units categorized as an acquisition. It does not report any open-market stock purchases or sales by Christopher Lynch in Tenet Healthcare common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/28/2026 - 08:00 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lynch Christopher S.

(Last)

(First)

(Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS

TEXAS

75254

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
2026 May Restricted Stock Units	⁽¹⁾	05/27/2026		A		1,188		05/27/2027	05/27/2027	Common Stock	1,188	$0	1,188	D

Explanation of Responses:

1. Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares.

	Chad J. Wiener, as Attorney-in-fact for Christopher S. Lynch	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR